CLASSYS Inc. (KOSDAQ:214150)

Market Cap	2.09T -43.6%
Revenue (ttm)	369.11B +25.5%
Net Income	137.63B +35.6%
EPS	2,098.90 +35.4%
Shares Out	65.22M
PE Ratio	15.27
Forward PE	11.65
Dividend	1,000.00 (3.20%)
Ex-Dividend Date	Dec 29, 2025

Volume	222,174
Open	30,250
Previous Close	31,000
Day's Range	30,250 - 32,350
52-Week Range	30,150 - 77,600
Beta	0.66
Analysts	Buy
Price Target	63,894.74 (+99.36%)
Earnings Date	Nov 12, 2026

About CLASSYS

CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that deliver...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 394
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214150

Financial Performance

In 2025, CLASSYS's revenue was 336.82 billion, an increase of 38.64% compared to the previous year's 242.94 billion. Earnings were 131.94 billion, an increase of 34.80%.

Analyst Summary

According to 19 analysts, the average rating for 214150 stock is "Buy." The 12-month stock price target is ₩63,895, which is an increase of 99.36% from the latest price.

Price Target

₩63,895

(99.36% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error